chlorthalidone
Coverage of chlorthalidone in the Nexus archive.
- Recall alert: 11K bottles of blood pressure medication recalled
The FDA recalled 11,460 bottles of 25mg chlorthalidone tablets due to failing dissolution specifications, distributed by Rising Pharma Holdings. The Class II recall indicates potential temporary adverse health effects.
- Blood pressure medication recalled nationwide: FDA
The FDA has issued a nationwide recall for 100 and 1,000 tablet bottles of Chlorthalidone. The recall applies to all bottles of this blood pressure medication sold nationwide.
- Blood pressure medication recalled nationwide: FDA
The FDA has recalled 100 and 1,000 tablet bottles of Chlorthalidone, a blood pressure medication, sold nationwide.
- Blood pressure medication recalled for potential ineffectiveness
The FDA recalled 11,460 bottles of chlorthalidone tablets due to potential ineffectiveness from failed dissolution specifications. The affected batches are RISA24001 (100-tablet bottles) and RISB24002 (1,000-tablet bottles), with an expiration date of April 2027. The medication is used to treat high blood pressure and fluid retention from conditions like heart failure, liver disease, kidney disease, or steroid treatments.
- Blood pressure medication recalled for potential ineffectiveness
The FDA recalled 11,460 bottles of chlorthalidone tablets, 25 mg, due to potential ineffectiveness caused by failed dissolution specifications. The affected batches are RISA24001 (100-tablet bottles) and RISB24002 (1,000-tablet bottles), with an expiration date of April 2027. Chlorthalidone is a diuretic used to treat high blood pressure and fluid retention.